In its commitment to excellence in research, the Josep Carreras Institute convenes this international conference to foster scientific collaboration between leading scientists and clinicians in the field of leukaemia and lymphoma. The programme will feature the most cutting-edge fields of hemato-oncology, as cell biology, immunology, genetics, epigenetics and computational biology, among others. The latest technologies like single-cell analysis, next generation sequencing and genome editing will also be key players of the event, with experts on the field commenting on the endless possibilities they open for research and diagnosis.

The Symposium will bring together leading scientists and physicians in the field of leukaemia and lymphoma, including our panel of selected speakers:

· Iannis Aifantis, New York University (NYU), New York, USA
· Francesco Bertoni, Institute of Oncology Research, Bellinzona, Switzerland
· Anna Bigas, Josep Carreras Leukaemia Research Institute (IJC), Hospital del Mar Research Institute, CIBERONC, Catalonia, Spain
· Vincenzo Calvanese, Josep Carreras Leukaemia Research Institute (IJC), Catalonia, Spain
· Jan Cools, KU Leuven, Center for Human Genetics, Belgium
· Matteo Della Porta, Humanitas Cancer Center, Milan, Italy
· Courtney DiNardo, MD Anderson, Houston, USA
· Manel Esteller, Josep Carreras Leukaemia Research Institute (IJC), CIBERONC, Catalonia, Spain
· Florian H. Heidel, Hannover Medical School (MHH), Germany
· Ross Levine, Memorial Sloan Kettering Institute, New York, USA
· Ari Melnick, Weill Cornell Medicine, New York, USA
· Michael Milsom, German Cancer Research Center (DKFZ), Heidelberg, Germany
· Teresa Palomero, Columbia University, New York, USA
· Bruno Paiva, Cima Universidad de Navarra Research Center (CIMA), Navarra, Spain
· Christoph Plass, German Cancer Research Center (DKFZ), Heidelberg, Germany
· Alberto Orfao, University of Salamanca, CIBERONC, Spain
· Brigitte Schlegelberger, Hannover Medical School (MHH), Germany
· Maria L. Toribio, Centro de Biología Molecular "Severo Ochoa", Madrid, Spain
· George Vassiliou, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK

Organizers: Laura Belver, Anna Bigas, Marcus Buschbeck and Manel Esteller.

During the symposium, world-class experts will share their views and thoughts on their journey against cancer from multiple points of view: cell biology, immunology, genetics, epigenetics and computational biology, among others. Together, we will gather an interdisciplinary representation of the finest researchers, from the basic and clinical sciences, to present their latest publications and discuss with their peers openly.

PROGRAMME
You can find the complete programme of the event here.

REGISTRATION & ABSTRACTS
Register now and submit your abstract via: https://eira.meetingpharma.com/courses/241120.LEUKAEMIA

Participants can register to the Symposium before Wednesday, 6 November 2024.

Participants are invited to submit abstracts for selection for oral and poster presentations. Abstracts should be submitted via the registration platform before Friday, 11 October 2024.

The Organizing Committee, on behalf of Molecular Oncology, FEBS’ open access journal on basic, translational, and clinical cancer research articles, will also award the prize for the best poster presented at the symposium.

The “Updates on Genetics and Epigenetics of Haematological Malignancies” Symposium receives support from dD Biolab, Cultek, Bonsai Lab, BGI, Ecogen, Active Motif (Condalab), Mission Bio Diagnóstica Longwood SL and The Company of Biologist.

With the participation of CIBERONC.

We hope that the conference will meet all expectations and that fruitful discussions and new collaborations will be established as a result.